CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for NOVARTIS · Bio-pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $20,000.00 income · posted Apr 18, 2025

Bills named in this filing 1

Lobbying activity 2

Health Issues

MINI Act HR 1672, Pharmaceutical Policy Issues

Medicare/Medicaid

MINI Act HR 1672, Pharmaceutical Policy Issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.